Amniotic fluid volume is an important indicator of fetal and placental well-being during pregnancy. At full term, a reduction in amniotic fluid may occur as a result of placental insufficiency, rupture of membranes, maternal dehydration, fetal urinary tract abnormalities, or other maternal and fetal conditions. Oligohydramnios is clinically significant because inadequate fluid surrounding the fetus reduces the protective cushioning effect and increases the possibility of umbilical cord compression during uterine contractions. This may result in variable fetal heart rate decelerations and signs of intrapartum fetal compromise. Reduced amniotic fluid is also associated with meconium passage and an increased probability of labor induction and operative delivery. Therefore, assessment of amniotic fluid volume in full-term pregnancy is important for identifying patients who require closer fetal surveillance and individualized delivery planning.
To evaluate the relationship between reduced amniotic fluid volume in full-term pregnancy and the frequency of maternal and fetal complications during labor.
The assessment includes pregnant women at 37–41 weeks of gestation who undergo routine clinical and ultrasound examination before delivery. Amniotic fluid volume is evaluated using ultrasound-based methods, including the amniotic fluid index or single deepest vertical pocket. Maternal characteristics, gestational age, history of pregnancy complications, and clinical indications for delivery are recorded. During labor, fetal well-being is monitored using cardiotocography and regular assessment of fetal heart rate. The occurrence of meconium-stained amniotic fluid, abnormal fetal heart rate patterns, umbilical cord compression, prolonged labor, and operative vaginal or cesarean delivery is evaluated. Maternal outcomes, including postpartum complications, are also considered. The relationship between reduced amniotic fluid volume and intrapartum outcomes is analyzed clinically.
Reduced amniotic fluid volume at full term is associated with a higher probability of intrapartum fetal heart rate abnormalities, particularly patterns compatible with umbilical cord compression. Insufficient amniotic fluid reduces the space between the fetus and uterine wall, decreasing the protective effect of the fluid during contractions. Patients with oligohydramnios may therefore require more intensive fetal monitoring during labor. A greater frequency of meconium-stained amniotic fluid may also be observed, which requires careful assessment of fetal condition and appropriate neonatal preparation. Reduced amniotic fluid is frequently accompanied by a higher rate of labor induction because of concerns regarding fetal and placental well-being. In cases where fetal compromise develops or labor does not progress adequately, operative delivery may become necessary. These findings indicate that oligohydramnios at term should not be considered an isolated ultrasound finding but rather a clinical factor requiring assessment in combination with fetal growth, placental function, fetal movements, and cardiotocographic findings.
A decrease in amniotic fluid volume during full-term pregnancy is clinically associated with an increased risk of several intrapartum complications, particularly fetal heart rate abnormalities, umbilical cord compression, meconium-stained amniotic fluid, and operative delivery. Ultrasound assessment of amniotic fluid volume combined with appropriate fetal surveillance provides valuable information for determining the optimal management strategy. The presence of oligohydramnios should prompt individualized evaluation rather than automatic intervention, taking into account gestational age, fetal condition, cervical status, membrane status, and other obstetric factors. Timely recognition and appropriate management of reduced amniotic fluid can contribute to safer labor and improved maternal and neonatal outcomes.
1. American College of Obstetricians and Gynecologists. Antepartum Fetal Surveillance. ACOG Practice Bulletin. Obstetrics & Gynecology.
2. American College of Obstetricians and Gynecologists. Medically Indicated Late-Preterm and Early-Term Deliveries. Obstetrics & Gynecology.
3. Rabie N, Magann E, Steelman S, Ounpraseuth S. Oligohydramnios in complicated and uncomplicated pregnancies: a systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology.
4. Morris JM, Thompson K, Smithey J, et al. The usefulness of ultrasound assessment of amniotic fluid volume in predicting adverse perinatal outcomes. American Journal of Obstetrics and Gynecology.
5. Magann EF, Chauhan SP, Doherty DA, et al. Predictability of the amniotic fluid index and single deepest pocket in identifying adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology.
6. Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database of Systematic Reviews.
7. Phelan JP, Ahn MO, Smith CV, Rutherford SE, Anderson E. Amniotic fluid index measurements during pregnancy. Journal of Reproductive Medicine.
8. Locatelli A, Vergani P, Toso L, Verderio M, Pezzullo JC, Ghidini A. Perinatal outcome associated with oligohydramnios in uncomplicated pregnancies. Archives of Gynecology and Obstetrics.
9. Williams JW, Cunningham FG, Leveno KJ, et al. Williams Obstetrics. McGraw-Hill.
10. Med1.uz. Oligohydramnios and pregnancy complications: clinical aspects of diagnosis and management. Medical information resource. https://med1.uz/